Related Experiment Video
Updated: Dec 24, 2025
09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
24.7K
A peptide-lipid nanoparticle assembly platform with integrated functions for targeted cell delivery
Qiao Wang1, Xiaochuan Ma, Junli Jia
1CAS Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, 398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu 215123, P. R. China. hfei2008@sinano.ac.cn.
Journal of Materials Chemistry. B
|April 9, 2020
Summary
This study introduces a peptide-lipid nanoparticle platform for drug delivery. This integrated system enhances nanoparticle stability and enables targeted delivery of hydrophobic drugs to cancer cells.
Area of Science:
- Biotechnology
- Nanomedicine
- Materials Science
Background:
- Liposomes are common drug carriers but face challenges in size, surface, and targeting control.
- Existing drug delivery systems require complex multi-step processes for nanoparticle formation and functionalization.
Purpose of the Study:
- To develop an integrated peptide-lipid nanoparticle (LNP) platform for efficient drug delivery.
- To create a versatile system for nanoparticle formation, surface functionalization, and hydrophobic drug loading.
Main Methods:
- Utilized a designer peptide (ALA peptide) with bivalent amphipathic α-helices to encapsulate lipid nanoparticles.
- Functionalized LNPs with penta-histidine for surface exposure demonstration and RGD peptides for targeted delivery.
- Encapsulated a cytotoxic iridium complex within RGD-inserted LNPs.
Main Results:
- The bivalency design improved peptide helicity, lipid-packaging efficiency, and stability of encapsulated hydrophobic molecules.
- Demonstrated successful surface functionalization and targeted delivery of RGD-LNPs to integrin-high cancer cells.
- Achieved selective cytotoxicity in cancer cells with reduced toxicity in non-cancer cells, highlighting the importance of RGD conformation.
Conclusions:
- Developed a simple and effective peptide-based LNP platform for integrated nanoparticle assembly and surface modification.
- The platform shows significant potential for targeted delivery of hydrophobic drugs, particularly in cancer therapy.
- Confirmed the necessity of a constrained cyclic RGD conformation for optimal targeting capability.
